Arjun Goyal, Director at Centessa Pharmaceuticals plc (CNTA), bought 925,170 shares at $12.24 ($11.7M) on 2025-05-15, disclosed to the SEC on 2025-05-19.
Open-market purchase of $11.7M CNTA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.24 | 44,939 | $550K | 4.7% |
| 2 | $12.24 | 44,939 | $550K | 4.7% |
| 3 | $12.73 | 417,646 | $5.3M | 45.3% |
| 4 | $12.73 | 417,646 | $5.3M | 45.3% |
| Total | $12.68 avg | 925,170 | $11.7M | 100% |